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The p53 tumor suppressor is a sequence-specific pleiotropic transcription factor that coordinates cellular responses to
DNA damage and stress, initiating cell-cycle arrest or triggering apoptosis. Although the human p53 binding site
sequence (or response element [RE]) is well characterized, some genes have consensus-poor REs that are nevertheless
both necessary and sufficient for transactivation by p53. Identification of new functional gene regulatory elements
under these conditions is problematic, and evolutionary conservation is often employed. We evaluated the
comparative genomics approach for assessing evolutionary conservation of putative binding sites by examining
conservation of 83 experimentally validated human p53 REs against mouse, rat, rabbit, and dog genomes and detected
pronounced conservation differences among p53 REs and p53-regulated pathways. Bona fide NRF2 (nuclear factor
[erythroid-derived 2]-like 2 nuclear factor) and NFjB (nuclear factor of kappa light chain gene enhancer in B cells)
binding sites, which direct oxidative stress and innate immunity responses, were used as controls, and both exhibited
high interspecific conservation. Surprisingly, the average p53 RE was not significantly more conserved than
background genomic sequence, and p53 REs in apoptosis genes as a group showed very little conservation. The
common bioinformatics practice of filtering RE predictions by 80% rodent sequence identity would not only give a
false positive rate of ;19%, but miss up to 57% of true p53 REs. Examination of interspecific DNA base substitutions as
a function of position in the p53 consensus sequence reveals an unexpected excess of diversity in apoptosis-regulating
REs versus cell-cycle controlling REs (rodent comparisons: p , 1.0 e 12). While some p53 REs show relatively high
levels of conservation, REs in many genes such as BAX, FAS, PCNA, CASP6, SIVA1, and P53AIP1 show little if any
homology to rodent sequences. This difference suggests that among mammalian species, evolutionary conservation
differs among p53 REs, with some having ancient ancestry and others of more recent origin. Overall our results reveal
divergent evolutionary pressure among the binding targets of p53 and emphasize that comparative genomics
methods must be used judiciously and tailored to the evolutionary history of the targeted functional regulatory
regions.
Citation: Horvath MM, Wang X, Resnick MA, Bell DA (2007) Divergent evolution of human p53 binding sites: Cell cycle versus apoptosis. PLoS Genet 3(7): e127. doi:10.1371/
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Introduction
Since the completion of the human genome, cataloging
transcription factor binding sites (TFBSs) has been critical for
understanding gene regulation. The use of comparative
genomics (evolutionary conservation across species) is often
championed as a method to separate the functional regu-
latory sequence ‘‘wheat’’ from the nonfunctional ‘‘chaff’’ [1].
As the number of mammalian full genome drafts increases,
the integration of TFBS predictions with lists of conserved
noncoding regions (CNCs) has emerged as a key step in the
TFBS identiﬁcation process [2–4]. If TFBS predictions are
contiguous to DNA features that coincidentally have a critical
structural role such as maintenance of chromatin organiza-
tion, the appearance of conservation may be intensiﬁed even
further.
Although these methods have greatly enhanced our knowl-
edge of the human genome’s regulatory repertoire, over-
reliance on conservation information can potentially exclude
genuine binding sites. Since TFBSs are typically small, they
can arise by chance in a gene’s promoter and therefore may
decrease selective pressures to maintain already existing sites
[5]. Another wrinkle is that the evolutionary forces that
created the conservation blocks may no longer be function-
ally relevant to humans [6]. Additionally, recent scans for
natural selection in human gene coding regions have revealed
that distinct biological pathways often are subject to widely
different evolutionary pressures [7,8], particularly since
mutation rates have been shown to vary across the genome
[9]. Genes involved in oncogenesis and tumor suppression
have experienced recent selection for mutation in primate
lineages [7,8,10]. DNA binding sites of transcription factors
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likely under similar evolutionary pressures. Indeed, we have
focused recently on identifying human single nucleotide
polymorphisms that alter the function of transcription
factors [11,12]. As a result, we have investigated the
assumptions for using mammalian conservation as an
obligatory screening step for seeking TFBSs.
The p53 tumor suppressor gene, encoded by the TP53
master regulatory gene, is a transcription factor that
coordinates a network of cellular responses to environmental
insults. Over half of human cancers have a mutation in the
p53 protein or one of its partners [13]. The p53 protein is
estimated to have several hundred transregulation target
genes that affect pathways including apoptosis, DNA damage
repair, and cell-growth arrest [14]. As a result, p53 target
genes are highly sought-after drug targets for halting cancer
progression. According to in vitro experiments, the p53
protein binds speciﬁcally to a palindromic consensus
sequence, RRRCWWGYYY(N0 13)RRRCWWGYYY [15], with
nearly all REs containing at least one mismatch; in vivo results
have suggested that the spacer region may be much smaller
[14,15]. The sequence is typically located within 5,000 bases of
the target gene’s transcriptional start site, and p53 either
induces or represses expression upon p53 binding [16,17].
One feature of p53 that confounds the discovery of novel
transregulated genes is that while some binding sites match
the expected consensus sequence quite well, others can be
consensus poor and yet are both necessary, and sufﬁcient, to
transactivate a gene [18]. A recent study has suggested that
the ‘‘rules of engagement’’ for p53 REs may differ based on
the activated pathway, particularly in the apoptosis and cell-
cycle–related systems [19]. Thus, we have used cross-species
conservation to examine if these groups of elements exhibit
distinct conservation proﬁles.
To evaluate the utility of comparative genomics approaches
in the identiﬁcation of potential p53 target REs, we gleaned
the literature for a high quality set of bona ﬁde p53 REs to
estimate the degree of conservation between humans and
other mammals. To relate the TP53 system to other master
regulators, we compare its binding site conservation to those
of the transcription factors encoded by two other genes: NFjB
(nuclear factor of kappa light chain gene enhancer in B-cells),
central to inﬂammation responses, and NFE2L2, which
encodes NRF2 (nuclear factor [erythroid-derived 2]-like 2
nuclear factor), a regulator of oxidative stress. Their reper-
toire of interactions is expected to be highly preserved
throughout the mammalian lineage. The NFjB transcription
factor is a heavily studied biological switch of the inﬂamma-
tion, apoptosis, and immune responses [20,21]. It binds the
consensus sequence GGGRNNYYCC [22,23], and its signaling
system is highly conserved even when examined in inverte-
brates [21,24]. NRF2 binds antioxidant REs (consensus
sequence ¼ TMANNRTGAYNNNGCRWWWW [25]) that are
comparable in size to those of p53, show high levels of
conservation [26], and are found in the promoters of genes
that confer protection from oxidative stress and chemical
carcinogens [27]. Mouse models of Nrf2-dependent response
to oxidative and electrophilic insults have been used to study
function [28,29]. Additionally, the Nrf2 pathway in zebraﬁsh
operates similarly to humans and underscores the likelihood
of high conservation in regulatory binding sites [30]. Because
the NFjB and NRF2 binding sites were determined to be
highly conserved, these two sets of TFBSs serve as positive
controls in estimates of conservation. Our comparative
genome analysis, which includes a coincident evaluation of
sampled promoter sequences and coding region sequence,
reveals that mammalian conservation does not apply to p53
target REs in general. However, among subgroups of target
genes we observe purifying selection acting on a number of
p53 binding sites, including many cell-cycle–related genes,




The literature was scanned for validated p53 (83, Table 1),
NFjB (21, Table 2), and NRF2 (21, Table 3) binding sites
associated with human genes. Human genome coordinates
were located and then referenced within global multiple
alignments held at the University of California Santa Cruz
[UCSC] (California, United States) genome browser website
[31] to ﬁnd their corresponding locations in eleven other
mammals. Using these global alignments, percent sequence
identity was calculated for each of the 125 binding sites across
the eleven mammals, with the calculation adapted to reﬂect
consensus sequence degeneracy, since every model RE had
positions where one or more of the four nucleotides could be
tolerated. Also, the p53 RE was unique in that the spacer
region between the two half sites could be any size or
sequence up to thirteen bases. We therefore calculated
sequence identity by omitting the p53 spacer region and
ignoring mismatches in the alignments that still ﬁt the TFBS
consensus (CDKN1A and PCNA examples shown in Figure 1,
others in Figure S3).
Figure 2 plots the conservation distribution for each set of
human TFBSs across mouse, rabbit, rat, and dog. Although
PLoS Genetics | www.plosgenetics.org July 2007 | Volume 3 | Issue 7 | e127 1285
Divergence of p53 Response Elements
Author Summary
The p53 tumor suppressor is a transcription factor that coordinates
cellular responses to DNA damage and stress, initiating cell-cycle
arrest or triggering apoptosis. Evolutionary conservation is often
employed to separate the functional ‘‘wheat’’ from the nonfunc-
tional ‘‘chaff’’ when identifying binding sites of transcription factors
like p53. We evaluated evolutionary conservation of 83 experimen-
tally validated human p53 binding sites against mouse, rat, rabbit,
and dog genomes, and similarly examined binding sites for two
other transcription factors as controls, NRF2 (nuclear factor
[erythroid-derived 2]-like 2 nuclear factor) and NFjB (nuclear factor
of kappa light chain gene enhancer in B cells), which direct oxidative
stress and innate immunity responses, respectively. NRF2 and NFjB
binding sites both exhibited high interspecific conservation,
indicative of purifying natural selection, but surprisingly, human
p53 response elements on average displayed a lack of conservation.
Thus conservation is not useful in the prediction of p53 binding
sites. After grouping p53 REs by gene ontology, we observed that
binding sites in cell-cycle genes like CDKN1A displayed high
conservation, while p53 binding sites in apoptosis and DNA repair
genes showed an unexpected excess of diversity and very little
homology with rodent sequences. Overall these results reveal
divergent evolutionary pressure among the binding targets of p53
and suggest caution in generalizing about the similarity of
regulation of the p53 pathway between humans and rodents.comparative data relating the chimpanzee and rhesus
monkey were also analyzed, we observed, as expected, that
these species were too evolutionary close to humans to be
informative (Figure S1). For example, nearly any human
sequence was in excess of 95% conserved in these two
primates. Also graphed in Figure 2 are the results for sets of
DNA sequence fragments randomly chosen from promoter
(gray) and protein-coding (blue) regions. This allows TFBS
conservation levels to be viewed in context of the evolu-
tionary pressures exerted on other genomic sequences. The
poorly conserved element shown in Figure 1 (PCNA) would
fall in a lower percentage bin (i.e., be on the left side of the
graph), as is the case for the randomly chosen promoter
sequences. The promoter fragments are representative of the
background genome sequence in which most TFBSs reside.
On the other hand, if TFBSs were very well conserved, then
the distribution would be right-shifted, as is the case for the
protein-coding region fragments (blue). To use conservation
as a metric to separate true binding sites from the rest of the
genome, their conservation should be signiﬁcantly greater
than that of randomly chosen promoter regions. The spike of
TFBSs at 0%–9% identity in each panel represents species-
speciﬁc sites that are essentially not present in the other
mammals.
For each of the human-to-mammal comparisons in Figure
2, NFjB and NRF2 sites produced identity distributions that
appear very similar to distributions from the coding region
fragment group (many sites with 90%–100% identity), which
was representative of genome sequence under high purifying
selection. This strongly suggests that NFjB and NRF2 sites
may be under purifying selection. The human-to-mammal
p53 site comparisons, on the other hand, produced con-
servation proﬁles in each species that have a high frequency
of sites at zero percent identity and fewer with 90%–100%
Table 1. Validated Human p53 TFBSs
Target Gene Sequence Function Target Gene Sequence Function
APAF1 AGACATGTCT(13)CGACAAGCCC Apoptosis BTG2 AGTCCGGGCA(1)AGCCCGAGCA Cell cycle
BAX TCACAAGTTA(1)AGACAAGCCT Apoptosis CDKN1A AAACATGCCC(11)CAACAAGCTG Cell cycle
BAX AGACAAGCCTGGGCGTGGGC Apoptosis CDKN1A GAAGAAGACTGGGCATGTCT Cell cycle
BBC3 CTGCAAGTCCTGACTTGTCC Apoptosis CDKN1A GAACATGTCCCAACATGTTG Cell cycle
BID GGGCATGATGGTGCATGCCT Apoptosis DUSP1 GAACTTGTCA(2)GGCTTTGTTT Cell cycle
CASP1 AGACATGCATATGCATGCAC Apoptosis GDF15 CATCTTGCCCAGACTTGTCT Cell cycle
CASP6 AGGCAAGGAG(4)AGACAAGTCT Apoptosis GDF15 AGCCATGCCCGGGCAAGAAC Cell cycle
CTSD AAGCTGGGCCGGGCTGACCC Apoptosis MDM2 GGTCAAGTTCAGACACGTTC Cell cycle
FOS GCGTGCGCTC(1)GAGCAAGTCC Apoptosis MDM2 GAGTTAAGTC(1)TGACTTGTCT Cell cycle
FOS ACGCTTGCCATAGTAAGAAT Apoptosis PLK2 AGACATGGTG(3)AAACTAGCTT Cell cycle
DCC1 CAGCATGTTCACACAAGCCA Apoptosis PLK2 AAACATGCCTGGACTTGCCC Cell cycle
FAS GGACAAGCCCTGACAAGCCA Apoptosis PLK2 GGTCATGATT(3)TAACTTGCCT Cell cycle
IGFBP3 AAACAAGCCA(1)CAACATGCTT Apoptosis PLK3 TAACATGCCC(6)AAGCGAGCGC Cell cycle
IGFBP3 GGGCAAGACCTGCCAAGCCT Apoptosis PTEN GAGCAAGCCC(14)GGGCATGCTC Cell cycle
LRDD AGGCCTGCCT(8)GGACATGTCT Apoptosis SESN1 GGACAAGTCTCCACAAGTCT Cell cycle
P53AIP1 TCTCTTGCCCGGGCTTGTCG Apoptosis SFN TAGCATTAGC(2)AGACATGTCC Cell cycle
PCBP4 GAACTTAAGA(10)GGACAAGTTG Apoptosis TP73 GGGCAAGCTGAGGCCTGCCC Cell cycle
PERP AGGCAAGCTCCAGCTTGTTC Apoptosis DKK1 AGCCAAGCTT(6)AACCAAGTTC Cell growth
PLAGL1 CAACTAGAC(4)TAGACTAGCTT Apoptosis EDN2 CTGCAAGCCCGGGCATGCCC Cell growth
PMAIP1 GAGCGTGTCCGGGCAGGTCG Apoptosis FLT1 GGACACGCTC(5)GGACCTGAGC Cell growth
TNFRSF10B GGGCATGTCCGGGCAAGACG Apoptosis NDRG1 CCACATGCAC(12)GCACATGAAC Cell growth
TNFRSF10C GGGCATGTCCGGGCAGGACG apoptosis SERTAD1 GGGCATGCGCCCTGAAGCCC Cell growth
TP53I3 CAGCTTGCCCACCCATGCTC Apoptosis TGFA GGGCAGGCCCTGCCTAGTCT Cell growth
TP53INP1 GAACTTGGGGGAACATGTTT Apoptosis DDB2 AAGCTGGTTTGAACAAGCCC DNA repair
TRAF4 GGGCAAGCCAGGGCCTGCCT Apoptosis GADD45A GAACATGTCTAAGCATGCTG DNA repair
SIVA CTACATGCACACGCATGCAT Apoptosis MLH1 AGGCATGTAC(2)CGCATGCCCA DNA repair
SIVA GTACTTGGCAGGGCATGTCT Apoptosis PCNA ACATATGCCCGGACTTGTTC DNA repair
SIVA GCACAAGCCT(5)TGTCTGGAGG Apoptosis PMS2 ATACTTGCTT(2)TTTCTTGTAA DNA repair
WIG1 AAACAAGTCCAGACATGCCT Apoptosis RRM2B TGACATGCCCAGGCATGTCT DNA repair
ADARB1 GTGCAAGTTTCAACTTGTCC RNA processing XRCC5 GAACTAGTTT(1)AAACATGTTC DNA repair
ARHGEF7 AAACATGTCAGCACTTGCTT Cell signaling ATF3 AGTCATGCCG(17)GGTCATGCCT Transcription factor
DUSP5 GCACTAGACA(1)GGGCTTGTTG Cell signaling C12ORF5 AGACAAGTCT(2)GGACATGTCT Metabolism
PDGFC GGTCATGTTCAGACTTGCCC Cell signaling PRKAB1 GTTCTTGCCGCGGCTTGCCT Metabolism
PPM1J GAACATGCCTGAGCAAGCCC Cell signaling SCGB1D2 GGTCTTGTTTAGACTTGCTC Unknown
DSC3 GAAGTTGCTC(6)AGGCAAGCCT Cell adhesion PHLDA3 GGTCAAGTTC(6)CAGCAGGCCA Unknown
MASPIN1 GAACATGTTG(1)AGGCCTTTTG Cell adhesion SERPINE1 ACACATGCCTCAGCAAGTCC Blood coagulation
MASPIN1 CAAGCTGCCA(2)AGGCTTGAGT Cell adhesion DDIT4 AAACAAGTCTTTCCTTGATC ROS regulation
MMP2 AGACAAGCCTGAACTTGTCT Angiogenesis FDXR GGGCAGGAGCGGGCTTGCCC ROS regulation
SEMA3B TTGCATGCCC(2)AGACATGTCT Development GPX1 GGGCCAGACCAGACATGCCT ROS regulation
EOMES GGGCCTGTCT(1)CAACTTGCCC Morphogenesis SCARA3 GGGCAAGCCCAGACAAGTTG ROS regulation
UBTD1 GAGCAAGCCCAGACTTGTCA Protein modification SOD2 GTGCTTGTTC(4)GGGCATGTCC ROS regulation
RPS27L GGGCATGTAGTGACTTGCCC Translation
p53 consensus sequence¼RRRCWWGYYY(N0 13)RRRCWWGYYY. The number of spacer bases are shown in parentheses. R¼Go rA ;W¼Ao rT ;Y¼C or T. ROS, Reactive oxygen species.
doi:10.1371/journal.pgen.0030127.t001
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Divergence of p53 Response Elementsidentity. This distribution is similar to the distribution
obtained from randomly sampled promoter fragments (gray),
which we used to represent genome sequence under neutral
selection. In mouse the p53 RE identity distribution was
correlated with the promoter fragment identity distribution
while NFjB and NRF2 showed less correlation with the
promoter distribution (Table S3).
Since p53 sites as a group were observed to have as many
interspeciﬁc substitutions as the background genomic se-
quence, use of conservation level to predicting bona ﬁde sites
would not be effective. However, this result could be due to
the fact that the set of 83 p53 TFBSs actually represents two
or more subsets of p53 REs with distinct conservation
proﬁles. A recent study hypothesized that the sequence
requirements of p53 REs may differ based on the activated
pathway such as apoptosis, DNA repair, cell-cycle check-
points, or cell-growth arrest [19]. We therefore investigated if
low and high percent identity values would apportion with
p53 REs grouped by function, thereby detecting evolutionary
divergence between p53 pathways.
Among these 83 p53 REs, we carried out analysis of the two
largest subgroups (Table 1), apoptosis-related (n ¼ 29) and
cell-cycle/cell-growth–related (n ¼ 23), on the basis of
observations of Qian et. al [19]. Average percent identity to
a consensus sequence was calculated for each of the tran-
scription factor groups, including the p53 subsets, and
compared via a two-tailed t-test assuming unequal variances
between the datasets. The results are displayed as odds ratios
(OR) in Table 4, and OR values represent the odds that one
type of human TFBS (columns) will be found as more
conserved than a second TFBS type (rows) in comparison
with other mammalian species. Ratios less than 1 (e.g., p53
apoptosis compared to all p53 sites) suggest lower conserva-
tion of the TFBS in the row. Among all species, the relative
conservation levels of NFjB compared to NRF2 sites were
similar and the p-values for difference were not signiﬁcant.
NFjB sites were signiﬁcantly more conserved than the entire
set of p53 sites in mouse and dog, while NRF2 sites were
signiﬁcantly more conserved than all p53 sites in mouse and
rat. The magnitude and statistical signiﬁcance of the differ-
ences between sequence motifs in Table 4 was greatest when
comparing either NRF2 or NFjB and the apoptotic p53 sites.
For example, in each species, the ORs for relative conserva-
tion between either NRF2 or NFjB and apoptosis genes were
all high (OR . 3.0) and at a signiﬁcance of at least p , 0.019.
On the other hand, the mean conservation level of the cell-
cycle–regulating p53 REs were not statistically different from
the NRF2 or NFjB sites. These observations imply that the
Table 2. Validated Human NRF2 TFBSs
Target Gene Sequence Target Gene Sequence
ABCC1 TCTGTGTGACTCAGCTTTGGA HMBS CTCCAGTGACTCAGCACAGGT
ETS1 AGCGGGTGACCAAGCCCTCAA NQO1 TCACAGTGACTCAGCAGAATC
FTH1 CCTCCATGACAAAGCACTTTT S100A6 GACACGTGACTCGGCAAGGGG
FTL TCAGCATGACTCAGCAGTCGC SAT CCGCTATGACTAAGCGCTAGT
GCLC TCCCCGTGACTCAGCGCTTTG SPTA1 ACTGGGTGACTCAGCAGTTTT
GCLM TAACGGTTACGAAGCACTTTC TBXAS1 AAGGAATGAATCAGCAACTTT
GCLM AGACAATGACTAAGCAGAAAT TXNRD1 TCAGAATGACAAAGCAGAAAT
GNAI2 AGCCTGTGACTGGGCCGGGGC TXNRD1 TCATTCTGACTCTGGCAGTTA
GPX2 CCAGGATGACTTAGCAAAAAC UGT1A6 TCTGTCTGACTTGGCAAAAAT
GSTP1 GCGCCGTGACTCAGCACTGGG UGT1A6 GAAAGCTGACACGGCCATAGT
HBB TCATCATGACTCAGCATTGCT
NRF2 consensus sequence ¼ TMAnnRTGAYnnnGCRWWW.
doi:10.1371/journal.pgen.0030127.t002
Table 3. Validated Human NFjB TFBSs
Target Gene Sequence Target Gene Sequence
SELE GGGGATTTCC TRAF1 GGGGAACTCT
PTGS2 GGGGATTCCC TNIP1 GGAAAGTCCC
MAT2A GGGAGGTGCC NFKBIA GGAAATTCCC
CCL20 GGGGAAAACC ALOX12 GGGACATCCC
IL8 TGGAATTTCC TP53 GGGGTTTTCC
CXCL1 GGGAATTTCC ICAM1 GGAAATTCCG
IRF1 GGGAATCCCG ZFP36 GGGGATCCGA
LTA GGGGCTTCCC SDC4 GGGGAATTCC
IL6 TGGGATTTTC ELK1 GGGAAGGGCC
SERPINE1 TGGAATTTCT F8 GGGACTTTTC
TNFRSF10B GGGAATTCCC
NFjB consensus sequence ¼ GGGRnnYYCC.
doi:10.1371/journal.pgen.0030127.t003
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Divergence of p53 Response Elementsmean p53 conservation level for all elements is really a
combination of the effect of the two ontological subgroups.
It has been proposed that an alternative method for
evaluating a DNA fragment’s conservation level is to ask
whether it sits within a block of conservation [6]. All bona
ﬁde TFBSs examined in this study were matched against the
‘‘most conserved’’ track of the UCSC genome browser to ask
whether a signiﬁcant proportion fell within conserved
blocks. Only 19.2% of all p53 REs mapped to these regions,
while 52.8% of NRF2 and 57.1% of NFjB TFBSs could be
colocated (Table 5). We also assessed the conservation of the
randomly chosen promoter sequences according to this
block method and used a two-tailed binomial test to
calculate statistical signiﬁcance. Intriguingly, all TFBS groups
mapped to more blocks than the random promoter
sequences except for the apoptosis subgroup of p53 REs.
These data mirrored the percent identity conservation
metric and again underscored that the apoptotic-regulating
p53 TFBSs may not have been under purifying selection
throughout mammalian evolution.
Inspection of the individual alignments between human
p53 REs and mouse reveal that 38% (11/29) apoptosis
elements and 9% (2/21) of cell-cycle element could not be
aligned with the multiz global alignment tool and thus
showed zero identity. Thus for human p53 REs in genes such
as BAX, FAS, PCNA, CASP6, SIVA1, and P53AIP1 we observed
little, if any, similarity with rodent sequences, and these
nonaligned sequences (zero identity) strongly impact the
calculations we have made.
Predictiveness of Mammalian Conservation for TFBSs
Although it was informative to know how well human p53
TFBSs are conserved relative to other regulatory motifs, an
aim of this study was to probe the utility of comparative
genomics for authenticating binding sites predicted by
computational methods. Receiver operator characteristic
(ROC) curves were employed to demonstrate the sensitivity
of TFBS prediction when qualiﬁed by conservation informa-
tion. ROC curves are traditionally used to measure the quality
of a binary classiﬁcation algorithm, as a discrimination
threshold is varied. Area under a ROC curve provides a
visual representation of how well the conservation metric can
classify the sets of bona ﬁde TFBSs as true positives. For
example, the area can be interpreted as the probability that
when both a bona ﬁde TFBS and a random promoter
sequence of equal lengths are chosen at random, the decision
function (conservation in a species) assigns a higher value to
the bona ﬁde TFBS. A perfect decision function would
generate a curve with an area of 1, meaning that 100%
sensitivity was obtained (i.e., all true positives were found),
and 100% speciﬁcity was reached (i.e., no false positives were
generated). If conservation predicted TFBS authenticity no
better than random chance, a line at 45 8 to the x-axis would
be generated that bisects the ROC space (area under the
curve [AUC] ¼ 0.5), because as the threshold is raised, equal
numbers of true and false positives compose the chosen set of
TFBSs. A ROC curve that fell below this diagonal would
indicate that conservation consistently predicted poorly,
meaning that one should employ the lack of conservation as
a decision classiﬁer to authenticate TFBSs.
When TFBS conservation was evaluated as a TFBS
predictor in each of the four mammals, bona ﬁde NRF2
and NFjB sites were consistently well predicted, whereas the
ROC curve describing all p53 sites approached the random
diagonal (Figure 3A–3D). The latter implies that conservation
analysis in these model organisms cannot enhance p53
binding site discovery, for the predictive capacity is only
slightly better than random. For example, if a cutoff of 80%
identity to mouse was employed as the rule for choosing p53
binding sites, only 43% of real p53 REs would be found, and
19% of the selections would be false positives (Figure 3A). We
were concerned that ascertainment bias (e.g., the presence of
spurious REs) in this large set of p53 sites might affect our
ﬁndings. However, the predictivity level for any of these
species does not change appreciably even when the p53 RE
list is restricted to only the 30 best-characterized sites (Figure
Figure 1. Examples of Calculated Interspecies Conservation Scores for
TFBSs
Multispecies alignments for p53 binding sites in the (A) CDKN1A and (B)
PCNA genes are shown. Mismatches (green) from human that do not
alter the p53 consensus motif, RRRCWWGYYY(N0 13)RRRCWWGYYY, do
not penalize the percent sequence identity, whereas consensus-altering
mismatches and insertion/deletion events do (red). For the p53 binding
sites, spacer elements are in gray and are not considered when
calculating percent identity. R ¼ Go rA ;W¼ Ao rT ;Y¼ Co rT .
doi:10.1371/journal.pgen.0030127.g001
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Divergence of p53 Response ElementsS2). In contrast, for NFjB an 80% mouse conservation
threshold would allow discovery of 86% of real NFjB sites
with a 25% false positive rate (Figure 3A). As a result, human/
mouse multiple sequence alignments are highly useful for
identifying novel NFjB sites but not so for p53 motifs. This
conclusion is reiterated in all four model organisms by
statistical evaluation of the AUC calculations (Table 6). p53
curves had smaller AUCs compared to those for NFjB and
NRF2.
A recent study noted that although the spacer region
between half sites for p53 REs can be zero to13 bases, small
spacers were overwhelmingly preferred in a distribution of
spacer length derived from genome-wide chromatin immu-
noprecipitation experiments [14]. This suggests that REs with
large spacers might not be valid, and we hypothesized that if
ROC curve analysis was restricted to only p53 REs with small
spacers (presumed higher quality), perhaps much greater
conservation would be observed. We examined the set of p53
REs having two or fewer spacer nucleotides between half sites
and observed no increase in conservation (Figure S2). Not
only was there no improvement in TFBS prediction sensi-
tivity for this subset, but the ROC areas were visibly greater
Figure 2. Distribution of Human-to-Mammal TFBS Conservation Scores
Graphed for each (human-to-mouse, -rabbit, -rat, and -dog) comparison in (A–D) are: the percentage of all TFBSs from each gene group (p53, 83 REs;
NRF2, 21 REs; or NFjB, 21 REs) that fall within the x-axis conservation bins (red bars); data for randomly sampled fragments from human coding regions
(blue bars); and gene promoters (gray bars). Coding regions (representing sequence under purifying selection) and randomly sampled promoter
regions (representing sequence under more neutral selection) were sampled 1,000 trials; error bars are narrower than the line art. Averages and
standard errors for the sets of known TFBSs are reported above each graph.
doi:10.1371/journal.pgen.0030127.g002
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Divergence of p53 Response Elementsfor rat and rabbit comparisons in the inverse set of REs (i.e.,
3þ spacer bases). Thus, as judged by conservation, p53 RE
spacer region length could not be considered a measure of RE
quality.
We then examined p53 RE conservation in light of gene
ontology. When p53 REs were subdivided based on functional
class, the sensitivity of interspeciﬁc conservation to predict
cell-cycle/cell-growth sites improved considerably, approach-
ing that for the NFjB and NRF2 targeted genes (Figure 3).
The p53 apoptotic REs (Figure 3, dashed line), on the other
hand, showed a dramatically different conservation proﬁle. In
the case of the mouse (AUC ¼ 0.616) and rat (AUC ¼ 0.568),
the ROC curve hovered just above the random line, which
indicates a lack of sensitivity. For two species (rabbit, AUC ¼
0.469 and dog, AUC ¼ 0.437), the sequence identity metric
had an apoptosis RE discovery rate worse than random
prediction. This suggests that the functional, apoptotic p53
binding sites are less conserved than randomly sampled
sequences in gene promoters. This phenomenon was also
observed when ROC curve analysis was carried out in other
distant mammalian species (tenrec, armadillo, elephant, and
opossum) (unpublished data).
One explanation for this provocative result could be that
apoptotic p53 sites might actually display a slightly different
consensus p53 binding site than that reported in the
literature. Perhaps a better-ﬁtting consensus would improve
conservation. We aligned all p53 sites (83), apoptotic (29), and
cell-cycle (23) p53 sites (Figure S3) and generated sequence
logos [32] (Figure S3A–3C) to identify improved patterns, but
while there are small differences, none ﬁt better than the
existing consensus of RRRCWWGYYYN0 13RRRCWWGYY.
Likewise, simply permitting any nucleotide at the least
compositionally biased positions in this p53 RE subset (bases
2, 8, 10, and 11 of the p53 consensus) did not improve the
area under the ROC curve (Figure S2). These data emphasize
not only that conservation analysis cannot improve identi-
ﬁcation of certain TFBSs like p53, but also that subclasses of
the same binding site may reﬂect distinct evolutionary
proﬁles.
Sequence Diversity as a Function of Position in the
Consensus Sequence
A second approach was used to detect if conservation
differed among nucleotide positions within the binding site.
That is, could we observe heightened human-to-mammal
interspeciﬁc substitutions or ‘‘sequence diversity’’ at partic-
ular locations within each TFBS consensus sequence? To
accomplish this, we aligned all TFBSs within each group (p53,
NRF2, or NFjB) and calculated the positional sequence
diversity, which was the percentage of aligned bases at each
position that varied from the accepted consensus sequence
(Figure 4). For example, in Figure 4A, the ﬁrst position in the
p53 consensus sequence differed from a purine base (R) at the
equivalent position in the mouse in 35% of all p53 TFBSs,
while positional diversity for randomly sampled promoter
sequence was 63% and that for coding region sequence was
25%. Highly conserved sequence would be plotted lower on
Table 4. Comparison of Mean TFBS Conservation Values (Mouse to Human, Rabbit to Human, Rat to Human, and Dog to Human)
Animal TFBS OR
a (p-value*)
TP53 (Apoptosis) TP53 (Cell Cycle) NRF2 NFKB
Mouse TP53 (all) 0.63 (0.218) 1.74 (0.101) 2.20 (0.038)* 3.18 (0.009)*
TP53 (apoptosis) 2.73 (0.023)* 3.44 (0.009)* 4.99 (0.003)*
TP53 (cell cycle) 1.26 (0.626) 1.82 (0.277)
NRF2 1.45 (0.544)
Rabbit TP53 (all) 0.38 (0.006)* 1.60 (0.261) 1.39 (0.438) 2.54 (0.393)
TP53 (apoptosis) 4.21 (0.006)* 3.67 (0.015)* 6.68 (,0.001)*
TP53 (cell cycle) 0.67 (0.793) 1.58 (0.421)
NRF2 1.82 (0.548)
Rat TP53 (all) 0.54 (0.105) 2.21 (0.020)* 2.89 (0.006)* 2.34 (0.066)
TP53 (apoptosis) 3.77 (0.003)* 5.26 (,0.001)* 4.25 (0.007)*
TP53 (cell cycle) 1.31 (0.586) 1.06 (0.919)
NRF2 0.81 (0.743)
Dog TP53 (all) 0.44 (0.020)* 1.33 (0.427) 1.40 (0.432) 3.37 (0.008)*
TP53 (apoptosis) 3.05 (0.012)* 3.18 (0.019)* 7.69 (,0.001)*
TP53 (cell cycle) 1.04 (0.933) 2.52 (0.107)
NRF2 2.41 (0.165)
aThe ORs are calculated as columns over rows. For example, in the human to mouse comparison, p53 cell cycle REs are 2.73 times more conserved than p53 apoptosis REs (p ¼ 0.023).
*Significant p-values for a two-tailed t-test between each sample’s mean conservation.
doi:10.1371/journal.pgen.0030127.t004
Table 5. Mapping of Human TFBSs to Hidden Markov Model-
Generated Conservation Blocks
TFBS Number Conserved Binding
Sites out of Total (%)
p-Value*
p53 16/83 (19.2%) 4.18e 5
p53, apoptosis 4/29 (13.8%) 0.22
p53, cell cycle 6/23 (26.1%) 0.002
NRF2 11/21 (52.8%) 4.00e 8
NFjB 12/21 (57.1%) 1.00e 9
*In a set of randomly chosen promoter regions of the same length, two-tailed binomial
probability of finding an equivalent or greater fraction of conserved sites.
doi:10.1371/journal.pgen.0030127.t005
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Divergence of p53 Response Elementsthe y-axis (less diversity) as displayed by the coding region
line (blue), while less conserved sequence would exhibit high
diversity and appear near the top of the graph (e.g., gray,
random promoter sequences). Small peaks observed in the
promoter and coding region plots reﬂect degeneracy of the
consensus sequence, with more degenerate positions exhibit-
ing less calculated diversity. Patterns of the promoter and
coding sequence lines are highly similar across species in
Figure 4 except for being shifted on the y-axis. This was an
expected feature of the data since these control curves were
plotted as the average result of 1,000 trials of sequence
fragment sampling across the human genome. When examin-
ing the population statistic of a large number of fragments,
the average coding or promoter region fragments will exhibit
similar transversion and transition mutation rates across
species, which are visualized in these patterns.
Figure 4D and 4E demonstrate that the positional sequence
diversity of NRF2 and NFjB sites mirrored coding region
sequence diversity across all species, as expected from the
previous conservation analysis (Figure 3). Figure 4C shows a
similar effect, with p53 cell-cycle–related sites displaying low
sequence diversity. Intriguingly, the apoptotic-related p53
binding sites (Figure 4B) showed levels of sequence diversity
that often met or exceeded those of the background
promoter sequences. In rabbit and dog these apoptotic p53
binding sites have diverged so much that they may have lost
function or could be under positive selection for mutation.
The differences in positional sequence diversity between the
two p53 RE subgroups were all highly signiﬁcant (two-tailed
paired t-test assuming unequal variances: dog ¼ 1.4e 13,
mouse ¼ 4.3e 12, rabbit ¼ 2.0e 17, and rat ¼ 2.0e 15). These
dramatic results indicate again that these different classes of
p53 binding sites may be subject to widely dissimilar sequence
constraints.
Discussion
The wide variety of genes transcriptionally regulated by p53
highlights the pleiotropic role of this master regulatory
protein in many different biological pathways. Here, we
addressed the conservation of human p53 binding sites across
several mammals commonly used as experimental models.
Examining global alignments of established human p53
binding sites, we found that common comparative genomics
methods do not generally enhance p53 binding site predic-
tion, although they can for NFjB, NRF2, and a subset of p53
target genes involved in cell-cycle regulation. This apparent
lack of conservation for many functional human p53 binding
sites suggests that regulation of the p53 response network may
Figure 3. ROC Curves for Four Mammalian Comparisons Indicate the Ability of Different Interspecific Comparisons to Identify Bona Fide Human TFBSs
(A–D) Using a dataset of experimentally verified human TFBSs and randomly chosen promoter sequences from human genes, the true positive and false
positive prediction rates were calculated given conservation thresholds that classify a TFBS as authentic or spurious. Each data point on a curve
represents a different conservation threshold for comparison in the indicated species. In (A) arrows indicate the 80% identity threshold. For NFjB 80%
identity with mouse is highly predictive for human. Prediction of apoptosis sites are similar to random classification (diagonal line).
doi:10.1371/journal.pgen.0030127.g003
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Divergence of p53 Response Elementsbe ﬁne tuned for the needs of each species. By comparing
sequence conservation between two p53 pathways, we have
detected differences in the evolution of their regulatory
elements. In particular, numerous functional human p53 REs
in apoptosis-regulating sites, as well as the surrounding local
sequence, show little homology to rodent sequences, suggest-
ing that this ontology may have been shaped by primate-
speciﬁc selection pressures that have resulted in turnover (loss
or gain) of binding sites. This is supported to some degree by
the very high mean sequence identity for all p53 REs between
human and chimpanzee or monkey (Figure S1). However,
turnover cannot be easily addressed by the global alignment
method. For example, a short species-speciﬁc rearrangement
such as an insertion of a repetitive DNA element (e.g., SINE,
LINE, etc.) that contains a RE would not globally align and
would show zero identity across species but might maintain
functional response across species.
There were also seven DNA repair-regulating p53 REs in
our dataset. Although there were not enough p53 RE sites to
perform a statistically signiﬁcant analysis, the average percent
identity to the consensus sequence was similar to that of the
apoptosis-related subset for human-to-rodent comparisons.
These ﬁndings are signiﬁcant considering the efforts to
functionally model human p53 responses in the mouse
(including cell cycle, apoptosis, and DNA repair) [33–35].
Complex molecular events (reviewed in [35]) regulate both
p53 levels and activity prior to the transregulation of cell-
cycle arrest and apoptosis genes. This results in large
increases in p53 availability for binding to REs. Presumably
the strength of p53 binding to a given target sequence has the
effect of tuning regulation of the components of the p53
network within a species. Our data suggest that regulation of
some p53 pathways, including apoptotic and DNA repair
genes, may differ between humans and other mammalian
species. Not only are REs in apoptotic and other genes
different from cell-cycle genes in rodents, but they appear to
differ from rabbits and dogs as well (Figure 4B). This
unexpected excess of sequence diversity for apoptotic
elements could be explained by recent positive selection in
all of these species. Support for this comes from an evolu-
tionary analysis of a functional, yet poor, consensus-matching
p53 RE in the apoptotic gene PIG3. This study revealed that
PIG3 became p53 responsive only recently, during primate
evolution [10] and is consequently only present and func-
tional in apes and humans.
A recent emergence of primate-speciﬁc apoptosis p53 RE
sites could explain the large number of interspeciﬁc differ-
ences identiﬁed following alignment to their orthologous
mouse, rat, rabbit, or dog sites (Figure 4). Dermitzakis and
Clark [36] observed a similar phenomena while surveying a
broad number of TFBSs and concluded that a large
percentage of apparently functional human sites were not
functional in rodents (and vice versa). The authors suggest
that loss and gain of TFBSs has been commonplace in both
rodents and humans. On the other hand, the p53 protein
itself has changed very little between species. Mouse and
human p53 proteins are 85% identical and show equivalent
transactivation of human apoptotic and cell-cycle REs in a
yeast-based system [37]. The DNA binding domain of the p53
protein has near 100% homology across all mammalian
species indicating strong purifying selection to maintain
DNA binding function. Our data indicate that cell-cycle REs
are also being maintained by purifying selection, while the
evidence suggests that divergent positive selection has
occurred among REs of apoptosis genes. The evolution of
apoptosis-related p53 binding sites has strong biological
plausibility, as it seems likely that such modiﬁcations could
profoundly affect how a species responds to environmental
stress and cellular damage. With exposure to DNA-damaging
agents being a common environmental feature throughout
mammalian history, selection pressure and the evolution of
systems to maintain genome stability could be quite different
in rodents and primates. For example, it was recently shown
that the Spalax (mole rat), which lives its entire life under-
ground, has a p53 protein with a very limited ability to induce
several well-known human apoptotic genes in reporter assays.
It is, however, quite capable of transactivating cell-cycle
arrest genes [38]. The adaptation of the Spalax p53 response
to a dramatically different environment underscores how
separate pathways jumpstarted by the same transcription
factor can have distinct evolutionary signatures.
Cross-species analysis of p53-regulated genes in relation to
biological function is largely absent. Thus it is unknown
whether any preservation of functionality in apoptosis-
related p53 binding sites exists, or if divergence and positive
selection have created uniquely primate response character-
istics. We are currently evaluating how p53 RE variation
across species affects binding and transactivation in a
functional model system and have observed that some weak
binding REs show high conservation (D. A. Bell, unpublished
data). Other aspects of p53 pathways may evolve, such as the
proteins that regulate the availability or quantity of active
p53 protein, so that the sequence and binding afﬁnity of
afﬁliated binding sites could be coevolving with such changes.
Table 6. Efficacy of Mammalian Conservation to Predict Human TFBSs
TFBS Area under ROC Curve
a
Mouse Rabbit Rat Dog
p53 0.696 (þ/ 0.041) 0.608 (þ/ 0.044) 0.674 (þ/ 0.042) 0.588 (þ/ 0.044)
p53, apoptosis 0.616 (þ/ 0.073) 0.469 (þ/ 0.075) 0.568 (þ/ 0.074) 0.437 (þ/ 0.074)
p53, cell cycle 0.783 (þ/ 0.060) 0.688 (þ/ 0.066) 0.798 (þ/ 0.058) 0.647 (þ/ 0.072)
NRF2 0.801 (þ/ 0.069) 0.666 (þ/ 0.084) 0.822 (þ/ 0.066) 0.672 (þ/ 0.083)
NFjB 0.852 (þ/ 0.060) 0.739 (þ/ 0.077) 0.802 (þ/ 0.069) 0.786 (þ/ 0.071)
aAn AUC of 1 would represent a conservation metric that perfectly identified genuine TFBSs. Standard errors for the curve areas are shown.
doi:10.1371/journal.pgen.0030127.t006
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Divergence of p53 Response ElementsThis study makes several suggestions for computational
analysis of p53 REs and regulatory sequence in general. Since
these binding sites seem to be experiencing much short-term
evolution and turnover, comparative genome analysis in a
panel of old and new world monkeys, ‘‘phylogenetic shadow-
ing,’’ may be a promising direction to enhance prediction
accuracy [1]. Secondly, among those p53 REs exhibiting high
conservation, mutations or polymorphisms that alter such
sequences may be signiﬁcant [35]. A key practical point is that
if comparative genomics methods are used to identify
putative functional regulatory regions, one should ensure
that the choice of comparative species data is relevant to the
selection pressure on the motifs of interest. For the p53
pathway, predictions based on mouse- or rat-to-human will
not only generate a large excess of false positives, but many
bona ﬁde REs will be missed.
Overall, conservation analysis may be a convenient
measuring stick for regulatory element function, but we have
shown that it must be used with caution and may depend on
the TFBS category being analyzed. A reduction in evolu-
tionary conservation in p53 regulatory elements is likely due
to species-speciﬁc selective pressures acting on the distinct
biological differences among p53-regulatory pathways.
Materials and Methods
TFBSs with experimental support were located in the literature
(see Table S1). Genome coordinates (National Center for Biotechnol-
ogy [NCBI] 35.1, May 2004 release) were located using BLAT [39]
Figure 4. Positional Diversity of Human TFBSs Compared to Four Species
(A–E) Sequence diversity is calculated as the percentage of aligned bases at a certain position that vary from the accepted transcription factor
consensus sequence, which is listed along the x-axis. The diversity levels of randomly chosen promoter sequences (gray) and randomly chosen coding
region (blue) sequences (1,000 trials, error bars are narrower than the data points) are plotted so that level of genuine TFBS diversity (red, known sites)
can be viewed in a genomic context. The shape of each plot reflects the level of degeneracy of the consensus at each nucleotide position (e.g., gray line,
the p53 consensus has C and G at fixed positions creating peaks in the samples from the promoter)
doi:10.1371/journal.pgen.0030127.g004
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Divergence of p53 Response Elementssearches against the human genome within the UCSC genome
browser (Table S2) [31,40]. If a TFBS could not be found in the
genome, it was removed from analysis, which left 83, 21, and 21
binding sites for p53, NRF2, and NFjB, respectively. The UCSC
‘‘multiz17way’’ conservation track [31,40,41] provided a 17-way
multiple sequence alignment between current releases of the Homo
sapiens genome and eleven additional mammals: Pan troglodytes
(chimpanzee, November 2003), Canis familiaris (dog, May 2005), Mus
musculus (mouse, May 2004), Rattus norvegicus (rat, June 2003), Macaca
mulatta (rhesus monkey, January 2006), Monodelphis domestica (opossum,
June 2005), Bos taurus (cow, March 2005), Echinops telfairi (tenrec, July
2005), Loxodonta africana (elephant, May 2005), Oryctolagus cuniculus
(rabbit, May 2005), and Dasypus novemcinctus (armadillo, May 2005).
This alignment set was used to ﬁnd the corresponding locations of
each TFBS within each genome. The accuracy of these alignment
regions were manually inspected and veriﬁed by both conﬁrming
similar local gene organization as well as referencing independently
generated paired human–mammal alignments (UCSC tables netMm7,
netMonDom1, netBosTau2, netRn4, netCanFam2, netRheMac2, and
netPanTro1) [42,43]. Similarly, a random list of promoter and cDNA
sequences were obtained from Ensembl (http://www.ensembl.org) by
referencing a genome coordinate list of all known human protein-
encoding genes (version 35.1) with an Ensembl gene identiﬁer [44].
For each gene, a coordinate range of length equal to the TFBS of
interest was randomly picked in the (a) 3,500 bases 59 to the gene start
site and (b) within protein coding DNA sequence. Sites from these
two lists of coordinates were randomly chosen to form a set of
genome regions with the same number of members as each TFBS
category: NRF2 (21), NFjB (21), p53 (83), p53 apoptosis (29), and p53
cell cycle/cell growth (23). This process was repeated 1,000 times with
replacement to capture the variance in the data. As with the known
TFBSs, the mammalian multiple alignment data from multiz17way
were retrieved for each of these promoter and cDNA sites. The
placement of target genes into p53 subcategories was based on the
grouping used in Qian et al. and an annotated literature search
(Table S1).
Pair-wise percent identities relative to the each TFBS consensus
were calculated as the percentage of RE bases that were either (a)
identical between the human and second genome or (b) mismatched
but do not deviate from the consensus sequence (Figure 1). For p53
REs, the variable spacer region was not considered. The distribution
of conservation for each TFBS set is shown in Figure 2. The
conservation of the randomly chosen sets of coding region and
promoter sequences, which represent the high and low extremes
respectively of human genome conservation for TFBS comparisons,
was calculated in the same fashion, and average results per x-axis bin
for 1,000 trials are shown in Figure 2. p-Values describing the
statistical difference between percent sequence identity means for
each TFBS set (Table 4) were calculated using an unpaired two-tailed
t-test with the assumption of unequal variances. The ORs in Table 4
were calculated as OR ¼ ad/bc, where a ¼ mean conservation of the
column element, b¼mean conservation of the row element, c¼100 
a, and d ¼ 100   b.
A list of CNC blocks, which represent the 5% most conserved
portions of the human genome, were downloaded from the ‘‘most
conserved’’ track of the UCSC genome browser. These were generated
by constructing a phylogenetic two-state Hidden Markov Model [45]
from the 17-way multiple alignment, which includes the human 35.1
genome release [31,41,44]. To generate the data in Table 5, the
coordinates of each TFBS set were intersected with the CNC blocks.
Likewise, the average number of randomly chosen promoter regions
(1,000 trials) found within CNCs was determined. The probability of
ﬁnding a greater fraction of CNCs in randomly chosen promoter
regionsoverTFBSsiteswascalculatedusinga two-tailedbinomialtest.
For the ROC curves in Figure 3, the sensitivity (true positive rate)
and 1-speciﬁcity (false positive rate) of TFBS prediction were
calculated at each of 11 conservation thresholds. The true positive
rate was the fraction of bona ﬁde TFBSs with a consensus sequence
percent identity above a given level. The false positive rate was
calculated as the average number of sites (1,000 trials) that fell above
a conservation threshold (consensus sequence percent identity) in an
equivalently sized set of random promoter sequences. For example,
83 TFBSs composed the p53 ROC curve. Therefore, sets of 83 random
promoter sites, where each site was 20 bases in length, were used to
estimate the false positive rate. ROC AUCs (Table 6) and standard
errors were calculated directly from the graphs using the trapezoid
rule as described by Hanley and McNeil [46].
Positional sequence diversity for a TFBS, which is related to the
inverse of sequence identity, was calculated as the percentage of
human nucleotides (nt) at each position that had a nonconsensus
mismatch or insertion/deletion event when compared to one of the
four mammals (Figure 4). Each TFBS of a given class (i.e., TP53) and
its alignment to a mammal (i.e., mouse) was pulled from the multiz
multiple alignments to produce a set of paired sequence alignments.
For each RE member of this pool, we counted the number of times
where the ﬁrst position of the mammalian sequence in the alignment
differed from the human nt due to either (a) a nonconsensus
mismatch or (b) an insertion/deletion event. This count was divided
by the total number of TFBSs in a group (i.e., 83 for all p53 REs or 21
for all NFjB REs) to get the percentage of two-way alignments that
differed at that position. This value is taken as the sequence diversity
at that ﬁrst position. This calculation was then performed for the
remaining nts in the TFBS. Mismatches from human that did not
alter the consensus motif did not increase the percent sequence
diversity and were ignored.
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